PELMEG 6mg 10mg/ml solution for injection in pre-filled syringe MUNDIPHARMA
pegfilgrastim Indicated for: neutropenia
letter P · page 21
pegfilgrastim Indicated for: neutropenia
nicotinic acid + laropiprant Indicated for: dyslipidemia
pemigatinib Indicated for: cancer
pemigatinib Indicated for: cancer
pemigatinib Indicated for: cancer
pemigatinib Indicated for: cancer
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues